肝硬化结节向肝细胞癌转化:自然病史与超声造影预测生物标志物
回顾性纳入39例患者44个病理证实的肝硬化结节,初次检出时行超声造影、其后每3-4个月常规超声随访,14个结节(31.8%)最终发生恶性转化;结节大小及结节与肝实质造影剂到达时间差>0.5秒为独立预测因素,随访中回声改变与生长率与恶性转化相关。
要点
- 初次超声造影中结节与肝实质造影剂到达时间差>0.5秒者恶性转化风险升高(HR 4.35)。
- 随访中6个月内绝对生长率≥5 mm或相对生长率≥30%可视为阈值生长,特异度与阳性预测值均为100.0%。
- 回声改变与阈值生长均缺如时排除恶性转化的敏感度与阴性预测值均为100.0%。
核心结论
- 初次检出时结节与肝实质造影剂到达时间差有助于对肝硬化结节最终恶性转化风险进行分层。
- 随访中生长率与回声改变和恶性转化相关,超声上的阈值生长可能被视为肝细胞癌无创诊断标准的潜在主要特征。
研究设计与样本
- 回顾性纳入39例连续患者共44个病理证实的肝硬化结节(平均大小17.5±8.5 mm),初次检出时行超声造影,其后每3-4个月行常规超声随访。
- 恶性转化依据肝细胞癌无创诊断标准或再次活检确定,从临床与超声变量中筛选恶性转化生物标志物并用ROC曲线评估其效能。
关键影像表现/征象
- 随访中位时间26.7个月,14个结节(31.8%)最终发生恶性转化。
- 随访期间回声改变(p=0.044)、绝对生长率(p<0.001)与相对生长率(p<0.001)与恶性转化相关。
诊断标准与关键数值
- 初次检出时结节大小(HR 1.07,p=0.019)与结节和肝脏造影剂到达时间差>0.5秒(HR 4.35,p=0.011)为恶性转化的独立预测因素。
- 初次结节大小的ROC曲线下面积Az=0.64(p=0.131),结节与肝脏造影剂到达时间差的Az=0.66(p=0.029),两者联合后Az=0.75(p=0.002)。
- 敏感度分析显示6个月内绝对生长率≥5 mm或6个月内相对生长率≥30%可作为识别恶性转化的阈值生长(特异度100.0%,阳性预测值100.0%)。
- 回声改变与阈值生长均缺如排除恶性转化的敏感度100.0%、阴性预测值100.0%。
临床应用与阅片要点
- 初次超声造影可测量结节与肝实质造影剂到达时间差,>0.5秒者提示最终恶性转化风险较高。
- 随访常规超声中关注回声改变及6个月内绝对生长率≥5 mm或相对生长率≥30%的阈值生长。
- 回声改变与阈值生长均缺如时,排除恶性转化的敏感度与阴性预测值均为100.0%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The objective of our study was to identify sonographic biomarkers predicting or indicating eventual malignant transformation of pathologically confirmed cirrhotic nodules. MATERIALS AND METHODS. Thirty-nine consecutive patients with 44 pathologically confirmed cirrhotic nodules (mean size, 17.5 ± 8.5 [SD] mm) who initially underwent contrast-enhanced ultrasound examination at detection and then underwent follow-up conventional ultrasound every 3-4 months thereafter were retrospectively included. Malignant transformation was identified on the basis of noninvasive diagnostic criteria for hepatocellular carcinoma or rebiopsy. Malignant transformation biomarkers were identified from clinical and sonographic variables and the performance thereof was evaluated using ROC curves. RESULTS. Fourteen nodules (31.8%) had eventual malignant transformation after a median follow-up time of 26.7 months. At initial detection, nodule size (hazard ratio [HR], 1.07; p = 0.019) and a contrast arrival time difference between the nodule and liver of more than 0.5 second (HR, 4.35; p = 0.011) were independent predictors for malignant transformation. The area under the ROC curve (Az) of initial nodule size (Az = 0.64, p = 0.131) and contrast arrival time difference between the nodule and liver (Az = 0.66, p = 0.029) improved after combining the two (Az = 0.75, p = 0.002). During follow-up, echogenicity change (p = 0.044), absolute growth rate (p < 0.001), and relative growth rate (p < 0.001) correlated with malignant transformation. Sensitivity analysis revealed that an absolute growth rate of 5 mm or greater in 6 months or a relative growth rate of 30% or greater in 6 months could be considered as threshold growth for identifying malignant transformation (specificity, 100.0%; positive predictive value, 100.0%). The absence of both echogenicity change and threshold growth was highly accurate in excluding malignant transformation (sensitivity, 100.0%; negative predictive value, 100.0%). CONCLUSION. The contrast arrival time difference between the nodule and liver at initial detection was useful in stratifying eventual malignant transformation risk for cirrhotic nodules. During follow-up, growth rate and echogenicity change correlated with malignant transformation; threshold growth on ultrasound may be considered a potential major feature in noninvasive diagnostic criteria of hepatocellular carcinoma.
引用
- Lin M, Lu DS, Duan Y, et al. Cirrhotic Nodule Transformation to Hepatocellular Carcinoma: Natural History and Predictive Biomarkers on Contrast-Enhanced Ultrasound. AJR Am J Roentgenol. 2019. PMID: 31642698. doi:10.2214/AJR.19.21739
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。